5/ …and analyze key differentiators, funding, pipelines, foundational innovation of 46 leading companies in our report.

4/ We’ve broken down the landscape of longevity biotech across five core technological approaches: •Removal •Replacement •Reprogramming •Metabolic modulation •Non-specific Discovery Platforms

2/ Why now? The convergence of breakthrough science in aging + accelerant technology (including AI) has sparked a new wave of startups. Visionaries are betting on longevity to be the next big thing: Bezos ($3B Altos) Sam Altman ($180M Retro Bio) Brian Armstrong ($105M NewLimit)